Original Article
Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine
Read
3375
Timeswas read the article
1487
Total PDF
1888
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 77 | 38 | 115 |
| 2025 5 | 95 | 42 | 137 |
| 2025 4 | 102 | 35 | 137 |
| 2025 3 | 68 | 35 | 103 |
| 2025 2 | 44 | 26 | 70 |
| 2025 1 | 40 | 31 | 71 |
| 2024 12 | 34 | 24 | 58 |
| 2024 11 | 37 | 33 | 70 |
| 2024 10 | 27 | 29 | 56 |
| 2024 9 | 42 | 22 | 64 |
| 2024 8 | 40 | 43 | 83 |
| 2024 7 | 85 | 38 | 123 |
| 2024 6 | 39 | 37 | 76 |
| 2024 5 | 27 | 21 | 48 |
| 2024 4 | 35 | 29 | 64 |
| 2024 3 | 53 | 21 | 74 |
| 2024 2 | 43 | 27 | 70 |
| 2024 1 | 33 | 29 | 62 |
| 2023 12 | 16 | 34 | 50 |
| 2023 11 | 23 | 39 | 62 |
| 2023 10 | 26 | 37 | 63 |
| 2023 9 | 33 | 37 | 70 |
| 2023 8 | 15 | 18 | 33 |
| 2023 7 | 26 | 21 | 47 |
| 2023 6 | 21 | 12 | 33 |
| 2023 5 | 39 | 21 | 60 |
| 2023 4 | 28 | 19 | 47 |
| 2023 3 | 51 | 26 | 77 |
| 2023 2 | 34 | 36 | 70 |
| 2023 1 | 20 | 31 | 51 |
| 2022 12 | 42 | 50 | 92 |
| 2022 11 | 48 | 34 | 82 |
| 2022 10 | 45 | 27 | 72 |
| 2022 9 | 30 | 57 | 87 |
| 2022 8 | 24 | 38 | 62 |
| 2022 7 | 25 | 38 | 63 |
| 2022 6 | 76 | 39 | 115 |
| 2022 5 | 38 | 32 | 70 |
| 2022 4 | 28 | 44 | 72 |
| 2022 3 | 60 | 54 | 114 |
| 2022 2 | 66 | 52 | 118 |
| 2022 1 | 67 | 45 | 112 |
| 2021 12 | 70 | 69 | 139 |
| 2021 11 | 16 | 17 | 33 |
Show all
